79 related articles for article (PubMed ID: 19601980)
1. Keratinocytes efficiently process endogenous antigens for cytotoxic T-cell mediated lysis.
Zhou F; Frazer IH; Leggatt GR
Exp Dermatol; 2009 Dec; 18(12):1053-9. PubMed ID: 19601980
[TBL] [Abstract][Full Text] [Related]
2. Interferon-gamma enhances cytotoxic T lymphocyte recognition of endogenous peptide in keratinocytes without lowering the requirement for surface peptide.
Leggatt GR; Dunn LA; De Kluyver RL; Stewart T; Frazer IH
Immunol Cell Biol; 2002 Oct; 80(5):415-24. PubMed ID: 12225377
[TBL] [Abstract][Full Text] [Related]
3. Tetramer-blocking assay for defining antigen-specific cytotoxic T lymphocytes using peptide-MHC tetramer.
Yokouchi H; Chamoto K; Wakita D; Noguchi D; Yamazaki K; Dosaka-Akita H; Nishimura M; Ikeda H; Nishimura T
Cancer Sci; 2006 Feb; 97(2):148-54. PubMed ID: 16441426
[TBL] [Abstract][Full Text] [Related]
4. The cytotoxic T lymphocyte response against a protein antigen does not decrease the antibody response to that antigen although antigen-pulsed B cells can be targets.
Wang W; Golding B
Immunol Lett; 2005 Sep; 100(2):195-201. PubMed ID: 15916814
[TBL] [Abstract][Full Text] [Related]
5. Primary T-cell and activated macrophage response associated with tumor protection using peptide/poly-N-acetyl glucosamine vaccination.
Maitre N; Brown JM; Demcheva M; Kelley JR; Lockett MA; Vournakis J; Cole DJ
Clin Cancer Res; 1999 May; 5(5):1173-82. PubMed ID: 10353754
[TBL] [Abstract][Full Text] [Related]
6. Human papillomavirus 16 E7 protein inhibits interferon-γ-mediated enhancement of keratinocyte antigen processing and T-cell lysis.
Zhou F; Leggatt GR; Frazer IH
FEBS J; 2011 Apr; 278(6):955-63. PubMed ID: 21232015
[TBL] [Abstract][Full Text] [Related]
7. Induction of cytotoxic T lymphocytes by primary in vitro stimulation with peptides.
Carbone FR; Moore MW; Sheil JM; Bevan MJ
J Exp Med; 1988 Jun; 167(6):1767-79. PubMed ID: 2455012
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxic T cell responses to DNA vaccination: dependence on antigen presentation via class II MHC.
Maecker HT; Umetsu DT; DeKruyff RH; Levy S
J Immunol; 1998 Dec; 161(12):6532-6. PubMed ID: 9862678
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic anti-tumor response induced with epitope-pulsed fibroblasts genetically engineered for B7.1 expression and IFN-gamma secretion.
Kim TS; Chung SW; Kim SH; Kang SN; Kang BY
Int J Cancer; 2000 Aug; 87(3):427-33. PubMed ID: 10897050
[TBL] [Abstract][Full Text] [Related]
10. Vaccination with dendritic cells pulsed in vitro with tumor antigen conjugated to cholera toxin efficiently induces specific tumoricidal CD8+ cytotoxic lymphocytes dependent on cyclic AMP activation of dendritic cells.
Sun JB; Eriksson K; Li BL; Lindblad M; Azem J; Holmgren J
Clin Immunol; 2004 Jul; 112(1):35-44. PubMed ID: 15207780
[TBL] [Abstract][Full Text] [Related]
11. Recognition of keratinocytes by cytotoxic T cells specific for conventional HLA class-I alloantigen.
Symington FW; Santos EB
J Invest Dermatol; 1990 Aug; 95(2):224-8. PubMed ID: 2116484
[TBL] [Abstract][Full Text] [Related]
12. Peptide affinity for MHC influences the phenotype of CD8(+) T cells primed in vivo.
Ma H; Kapp JA
Cell Immunol; 2001 Nov; 214(1):89-96. PubMed ID: 11902833
[TBL] [Abstract][Full Text] [Related]
13. Delivery by Trypanosoma cruzi of proteins into the MHC class I antigen processing and presentation pathway.
Garg N; Nunes MP; Tarleton RL
J Immunol; 1997 Apr; 158(7):3293-302. PubMed ID: 9120286
[TBL] [Abstract][Full Text] [Related]
14. Effective induction of anti-tumor immune responses with oligomannose-coated liposome targeting to intraperitoneal phagocytic cells.
Ikehara Y; Shiuchi N; Kabata-Ikehara S; Nakanishi H; Yokoyama N; Takagi H; Nagata T; Koide Y; Kuzushima K; Takahashi T; Tsujimura K; Kojima N
Cancer Lett; 2008 Feb; 260(1-2):137-45. PubMed ID: 18077084
[TBL] [Abstract][Full Text] [Related]
15. Human papillomavirus 16-encoded E7 protein inhibits IFN-γ-mediated MHC class I antigen presentation and CTL-induced lysis by blocking IRF-1 expression in mouse keratinocytes.
Zhou F; Chen J; Zhao KN
J Gen Virol; 2013 Nov; 94(Pt 11):2504-2514. PubMed ID: 23956301
[TBL] [Abstract][Full Text] [Related]
16. Cytotoxic T-cells specific for natural IgE peptides downregulate IgE production.
Chen SS; Gong J; Yang YM; Oettgen H; Zanetti M
Cell Immunol; 2005 Jan; 233(1):11-22. PubMed ID: 15913585
[TBL] [Abstract][Full Text] [Related]
17. Clonal analysis of cytolytic T lymphocyte-mediated lysis of target cells with inducible antigen expression: correlation between antigen density and requirement for Lyt-2/3 function.
Shimonkevitz R; Luescher B; Cerottini JC; MacDonald HR
J Immunol; 1985 Aug; 135(2):892-9. PubMed ID: 2409156
[TBL] [Abstract][Full Text] [Related]
18. T lymphocyte responses to multiple minor histocompatibility antigens generate both self-major histocompatibility complex-restricted and cross-reactive cytotoxic T lymphocytes.
Tremblay N; Fontaine P; Perreault C
Transplantation; 1994 Jul; 58(1):59-67. PubMed ID: 8036709
[TBL] [Abstract][Full Text] [Related]
19. Definition of an immunogenic region within the ovarian tumor antigen stratum corneum chymotryptic enzyme.
Bondurant KL; Crew MD; Santin AD; O'Brien TJ; Cannon MJ
Clin Cancer Res; 2005 May; 11(9):3446-54. PubMed ID: 15867247
[TBL] [Abstract][Full Text] [Related]
20. Generation of tumor-specific cytotoxic T lymphocyte and prolongation of the survival of tumor-bearing mice using interleukin-18-secreting fibroblasts loaded with an epitope peptide.
Chung SW; Cohen EP; Kim TS
Vaccine; 2004 Jun; 22(20):2547-57. PubMed ID: 15193380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
